PRESS RELEASE published on 03/07/2025 at 08:29, 1 year ago Inside Information / Operations of the issuer (acquisitions, sales...) GenSight Biologics announces c. €0.9 million financing round for innovative gene therapy program. Financing from existing investors supports LUMEVOQ access for patients. Business update includes 2024 annual results and working capital statement Financing Business Update Gene Therapy GenSight Biologics LUMEVOQ
PRESS RELEASE published on 03/07/2025 at 08:29, 1 year ago Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...) GenSight Biologics annonce un financement de 0,9 million d'euros auprès d'investisseurs existants. Augmentation de capital pour avancer ses recherches thérapeutiques essentielles Financement GenSight Biologics Thérapies Géniques Investisseurs Existants Recherche Thérapeutique
BRIEF published on 02/27/2025 at 09:02, 1 year ago GenSight Biologics : Résultats Financiers 2024 et Perspectives Résultats Financiers 2024 Gestion De Trésorerie Financement Futur Térapie Génique Accès Compassionnel LUMEVOQ
BRIEF published on 02/27/2025 at 09:02, 1 year ago GenSight Biologics: 2024 Financial Results and Outlook Gene Therapy Cash Management Financial Results 2024 Future Financing LUMEVOQ Compassionate Access
PRESS RELEASE published on 02/27/2025 at 08:57, 1 year ago Informations privilégiées / Communiqué sur comptes, résultats GenSight Biologics publie ses résultats financiers estimés pour l'année 2024. L'entreprise prolonge son horizon de trésorerie jusqu'à avril 2025 grâce à une gestion rigoureuse et au Crédit d'Impôt Recherche Résultats Financiers Trésorerie GenSight Biologics Crédit D'Impôt Recherche AAC
PRESS RELEASE published on 02/27/2025 at 08:57, 1 year ago Inside Information / News release on accounts, results GenSight Biologics reports estimated full-year 2024 consolidated financial results. Cash runway extended to early April 2025. Resumption of Compassionate Access Program expected in April 2025 Financial Results 2024 GenSight Biologics Cash Runway Compassionate Access Program
BRIEF published on 02/12/2025 at 07:35, 1 year 1 month ago GenSight Biologics Reports Positive Five-Year Outcomes for LUMEVOQ® Gene Therapy Gene Therapy LUMEVOQ® Visual Acuity Safety Profile REFLECT Study
BRIEF published on 02/12/2025 at 07:35, 1 year 1 month ago GenSight Biologics annonce des résultats positifs sur cinq ans pour la thérapie génique LUMEVOQ® Thérapie Génique LUMEVOQ® Acuité Visuelle Profil De Sécurité Étude REFLECT
PRESS RELEASE published on 02/12/2025 at 07:30, 1 year 1 month ago Inside Information / Other news releases GenSight Biologics reports 5-year efficacy and safety results for LUMEVOQ® gene therapy in REFLECT study with sustained visual improvement and favorable safety profile Gene Therapy GenSight Biologics LUMEVOQ Visual Acuity REFLECT Study
PRESS RELEASE published on 02/12/2025 at 07:30, 1 year 1 month ago Informations privilégiées / Autres communiqués GenSight Biologics annonce les résultats à 5 ans de la thérapie génique LUMEVOQ® pour la NOHL, confirmant l'efficacité durable et le profil de sécurité favorable Sécurité Efficacité Thérapie Génique GenSight Biologics LUMEVOQ
Published on 03/23/2026 at 22:40, 2 hours 52 minutes ago Troubadour Announces Withdrawal of Non-Brokered Private Placements
Published on 03/23/2026 at 22:30, 3 hours 2 minutes ago Gregory J. Leia Sells Shares in Waskahigan Oil & Gas Corp
Published on 03/23/2026 at 22:00, 3 hours 32 minutes ago Hillcrest Participates in APEC 2026 and Announces Shares for Debt Offering
Published on 03/23/2026 at 21:18, 4 hours 14 minutes ago Amdocs Announces Appointment of Shimie Hortig to the Board of Directors Upon Shuky Sheffer's Retirement as Director and Chief Executive Officer
Published on 03/24/2026 at 00:55, 36 minutes ago mymediset Introduces Agentic AI for MedTech Supply Chains at LogiMed 2026
Published on 03/24/2026 at 00:09, 1 hour 22 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3C - change of buy back details
Published on 03/23/2026 at 22:05, 3 hours 26 minutes ago DeFi Technologies Provides Update on Timing of Annual Filings
Published on 03/23/2026 at 21:05, 4 hours 26 minutes ago Abivax annonce ses résultats financiers pour l’exercice 2025 et fait le point sur l’avancement de ses activités
Published on 03/23/2026 at 21:05, 4 hours 26 minutes ago Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Published on 03/23/2026 at 19:08, 6 hours 23 minutes ago Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 19:08, 6 hours 23 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Published on 03/23/2026 at 18:37, 6 hours 54 minutes ago ALTAREA : Déclaration d’opérations sur actions propres
Published on 03/23/2026 at 17:45, 7 hours 46 minutes ago ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 7 hours 46 minutes ago En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde
